Examination of three large breast cancer datasets show that elevated levels of YBX1 (hereafter referred to as YB-1) transcripts are associated with a reduced overall survival of patients with ER- breast cancers, most notably in those with metastatic disease [19–21]. This evidence concerns the gene YBX1 and metastatic neoplasm.